COM:FOGHORNTX
Foghorn Therapeutics Inc.
- Stock
Last Close
7.86
21/11 21:00
Market Cap
265.58M
Beta: -
Volume Today
69.99K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -26.34M - | -51.13M 94.13% | -68.80M 34.56% | -101.32M 47.27% | -108.88M 7.46% | -98.43M 9.60% | |
depreciation and amortization | 379K - | 693K 82.85% | 1.33M 91.49% | 3.23M 143.18% | 3.32M 2.91% | 8.66M 160.79% | |
deferred income tax | 30K - | 10K 66.67% | 84K 740% | 1.41M 1,580.95% | -846K - | ||
stock based compensation | 732K - | 1.69M 131.42% | 2.96M 74.79% | 8.38M 183.15% | 14.34M 70.99% | 16.19M 12.90% | |
change in working capital | 2.42M - | 1.20M 50.62% | 28.70M 2,297.91% | 33.44M 16.51% | 281.55M 741.92% | -41.88M 114.87% | |
accounts receivables | -300M - | 300M 200% | |||||
inventory | -3.17M - | ||||||
accounts payables | 1.28M - | 1.21M 5.09% | 474K 60.86% | 135K 71.52% | 1.61M 1,095.56% | 846K 47.58% | |
other working capital | 1.15M - | -14K 101.22% | 28.23M 201,735.71% | 336.48M 1,091.96% | -20.07M 105.96% | -42.73M 112.90% | |
other non cash items | 124K - | 1.20M 866.94% | 4.44M 270.23% | 4.61M 3.76% | 3.29M 28.55% | -1.80M 154.76% | |
net cash provided by operating activities | -22.65M - | -46.34M 104.59% | -31.29M 32.48% | -50.25M 60.61% | 193.61M 485.30% | -118.11M 161.00% | |
investments in property plant and equipment | -1.54M - | -968K 37.18% | -16.18M 1,571.80% | -3.31M 79.53% | -1.21M 63.48% | -1.22M 1.16% | |
acquisitions net | 4K - | 250K 6,150% | -39.49M 15,894.40% | 243.11M 715.69% | |||
purchases of investments | -92.98M - | -99.98M 7.53% | -409.35M 309.41% | -73.90M 81.95% | |||
sales maturities of investments | -250K - | 139.47M 55,888% | 166.23M 19.19% | 219.57M 32.09% | |||
other investing activites | 250K - | 39.49M 15,694.40% | -243.11M 715.69% | ||||
net cash used for investing activites | -1.54M - | -964K 37.44% | -108.91M 11,198.13% | 36.17M 133.21% | -244.32M 775.43% | 144.45M 159.12% | |
debt repayment | -823K - | -7.98M 870.11% | -15.53M 94.51% | -21.20M 36.54% | |||
common stock issued | 15.98M - | 122.12M 663.97% | 42.20M 65.44% | 1.76M 95.82% | 1.78M 0.85% | ||
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | 52.59M - | 15.97M 69.64% | 110.88M 594.40% | 1.42M 98.72% | |||
net cash used provided by financing activities | 51.77M - | 23.97M 53.70% | 217.47M 807.31% | 22.42M 89.69% | 1.76M 92.14% | 1.78M 0.85% | |
effect of forex changes on cash | |||||||
net change in cash | 27.58M - | -23.33M 184.59% | 77.27M 431.22% | 8.34M 89.21% | -48.95M 686.82% | 28.12M 157.45% | |
cash at beginning of period | 13.00M - | 40.59M 212.10% | 17.25M 57.48% | 94.53M 447.83% | 102.87M 8.82% | 52.21M 49.24% | |
cash at end of period | 40.59M - | 17.25M 57.48% | 94.53M 447.83% | 102.87M 8.82% | 53.92M 47.58% | 80.34M 48.99% | |
operating cash flow | -22.65M - | -46.34M 104.59% | -31.29M 32.48% | -50.25M 60.61% | 193.61M 485.30% | -118.11M 161.00% | |
capital expenditure | -1.54M - | -968K 37.18% | -16.18M 1,571.80% | -3.31M 79.53% | -1.21M 63.48% | -1.22M 1.16% | |
free cash flow | -24.19M - | -47.30M 95.56% | -47.47M 0.35% | -53.56M 12.84% | 192.40M 459.21% | -119.33M 162.02% |
All numbers in (except ratios and percentages)